Induced Pluripotent Stem Cells (iPS) – Human Cell Lines
Drug Discovery, Screening and Development
FDA Clinical Trial Process
Phase I Clinical Trial – A phase I clinical trial tries to show that people can safely use a new drug or treatment.
Phase II Clinical Trial -Phase II clinical trials give doctors more information about the treatment’s safety and how well it works
Phase III Clinical Trial – Phase III clinical trials start with a new treatment that’s worked well in a small number of patients with a certain disease
The average time from clinical trial start to completion is 6 years according to the FDA. According to the Tufts center for the study of drug development the newest estimate for the cost to develop and bring a drug to market is $2.6 billion. Because of the enormous costs, it is critical that patient groups, research scientists and doctors collaborate throughout the process.